Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of VaxigripTetra in Vietnamese participants aged 6 months and older
2019-002218-38Phase 3
- Sponsor
- Sanofi
- Start
- Jul 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Vaxigrip in influenza, sponsored by Sanofi. Primary endpoint: Unsolicited systemic adverse events within 30 minutes after vaccination.
02
Drugs
Vaxigrip
03
Conditions
influenza
Beyond the preview
Go deeper on 2019-002218-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002218-38.